SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-23-015893
Filing Date
2023-09-20
Accepted
2023-09-20 09:59:02
Documents
13
Period of Report
2023-09-19
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A nhwk-20230919x8ka.htm   iXBRL 8-K/A 43600
  Complete submission text file 0001558370-23-015893.txt   198730

Data Files

Seq Description Document Type Size
2 EX-101.SCH nhwk-20230919.xsd EX-101.SCH 4305
3 EX-101.DEF nhwk-20230919_def.xml EX-101.DEF 14026
4 EX-101.LAB nhwk-20230919_lab.xml EX-101.LAB 20095
5 EX-101.PRE nhwk-20230919_pre.xml EX-101.PRE 13690
7 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20230919x8ka_htm.xml XML 7098
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35994 | Film No.: 231265518
SIC: 2834 Pharmaceutical Preparations